Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: Implications for a theory of schizophrenia

In rats, chronic (12 days) amphetamine administration (5 mg/kg, s.c.) resulted in more than 30% decrease of the glutamate content in the cerebrospinal fluid (CSF) and concomitant increase of glutamate levels in the frontal cortex, striatum and hippocampus. In contrast, chronic amphetamine had no effect on the GABA contents in these areas. The data are compatible with the interpretation that amphetamine induces an increase of dopaminergic function in these brain regions which results in an enhanced inhibition of glutamate release. It is hypothesized that diminished glutamate release accompanies the amphetamine psychosis as well as schizophrenia.

[1]  M. Cuénod,et al.  Glutamate release in vitro from corticostriatal terminals , 1979, Brain Research.

[2]  P. Spano,et al.  Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. , 1978, Life sciences.

[3]  S. Snyder,et al.  Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.

[4]  M. H. Aprison,et al.  Fluorometric determination of aspartate, glutamate, and γ-aminobutyrate in nerve tissue using enzymic method☆ , 1966 .

[5]  P. Mcgeer,et al.  A glutamatergic corticostriatal path? , 1977, Brain Research.

[6]  J. Coyle,et al.  Evidence for a hippocampal-septal glutamatergic pathway in the rat , 1979, Experimental Neurology.

[7]  F. Fonnum,et al.  Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain , 1980, Neuroscience.

[8]  I. Divac,et al.  High affinity uptake of glutamate in terminals of corticostriatal axons , 1977, Nature.

[9]  R. Hassler,et al.  Effect of frontal cortex ablation on striatal glutamic acid level in rat , 1977, Brain Research.

[10]  H. H. Kornhuber,et al.  Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.

[11]  G. F. Rowlands,et al.  Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro. , 1980, European journal of pharmacology.